Merck & Co. Ordered to Disclose Internal Emails In Zostavax Lawsuit

Merck & Co. Ordered to Disclose Internal Emails In Zostavax Lawsuit
Dec 4, 2020 Marti Thurman Read Time: < 1 minute

December 23, 2020 — Judge Harvey Bartle ruled that all but part of one of the 22 documents in dispute were not shielded by the attorney-client privilege.  Accordingly, Merck & Co. is required to disclose internal emails about potential changes to the label of Zostavax, which could reveal its knowledge of the adverse effects its vaccine was causing long before it actually made the label change in 2014.

Reference:

Pierson, Brendan. “Merck Must Turn over Emails in Zostavax MDL, despite Claims of Privilege.” Reuters, Thomson Reuters, 24 Dec. 2020, www.reuters.com/article/health-zostavax/merck-must-turn-over-emails-in-zostavax-mdl-despite-claims-of-privilege-idUSL1N2J41FA.

By: Marti Thurman

Marti Thurman is an experienced, driven attorney who dedicates herself fully to her clients. She has worked with insurance companies as a defense attorney in the past, so she understands the tactics these companies use to reduce compensation to victims. This experience drives her to push hard for her clients, and to never settle for less than a case is worth. Marti graduated magna cum laude from the University of Louisville and near the top of her class from the University of Louisville Louis D. Brandeis School of Law

(888) 437-5464
Jump to a Topic  Schedule Your Free Consultation